Role of Hematopoietic Growth Factors as Adjuncts in the Treatment of Chronic Hepatitis C Patients

Drug-induced hematotoxicity is the most common reason for reducing the dose or withdrawing ribavirin (RBV) and interferon (IFN) therapy in chronic hepatitis C, which leads to the elimination of a possible cure for the patient. Traditionally, severe anemia and neutropenia have been considered as abso...

Descripción completa

Detalles Bibliográficos
Autores principales: Danish, Fazal A., Koul, Salman S., Subhani, Fazal R., Rabbani, Ahemd E., Yasmin, Saeeda
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
New Horizon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702921/
https://www.ncbi.nlm.nih.gov/pubmed/19568529
http://dx.doi.org/10.4103/1319-3767.41739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702921/
https://www.ncbi.nlm.nih.gov/pubmed/19568529
http://dx.doi.org/10.4103/1319-3767.41739

Ejemplares similares